CANCER STEM CELL GROWTH INHIBITOR USING miRNA

    公开(公告)号:US20210052627A1

    公开(公告)日:2021-02-25

    申请号:US16498986

    申请日:2018-03-30

    Abstract: The purpose of the present invention is to provide a nucleic acid medication for cancer treatment, the medication being capable of suppressing the growth of cancer stem cells and thus effectively treating cancer. hsa-miR-136-5p, hsa-miR-3065-3p, hsa-miR-4727-5p, hsa-miR-378g, hsa-miR-181a-5p, hsa-miR-362-5p, and hsa-miR-608 have remarkably excellent growth inhibitory action on cancer stem cells and are thus useful as a nucleic acid medication for the treatment of various cancers.

    CANCER STEM CELL
    3.
    发明申请
    CANCER STEM CELL 审中-公开

    公开(公告)号:US20200040307A1

    公开(公告)日:2020-02-06

    申请号:US16499094

    申请日:2018-03-30

    Abstract: The purpose of the present invention is to provide: a cancer stem cell having an excellent ability to form tumor tissue; and a method for establishing the cancer stem cell. Cells having a low metabolic function of 26S proteasome are isolated and concentrated from a cancer stem cell group containing cancer stem cells, thereby obtaining cancer stem cells which can form tumor tissue in a living body even when the number of cells is 200 or less.

Patent Agency Ranking